Another covid drug bites the dust? Excerpts fro
Post# of 148126
Excerpts from article published today in The New Indian Express:
"NEW DELHI: The National Task Force on COVID-19 has decided not to recommend the drug itolizumab in the national protocol for treating the infection for now despite the drug regulator's decision to authorize its emergency use in patients recently."
"In its meeting on Friday, most members of the task force felt that the evidence cited in favour of the medicine is "inconclusive"."